A broad coalition of public policy, free-market, and grassroots organizations has sent a letter to Republican lawmakers urging support for three crucial pieces of patent legislation: the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act, the Patent Eligibility Restoration Act (PERA), and the RESTORE Patent Rights Act. These Read more…
Market Institute marked World Intellectual Property Day with the official launch of the Congressional Inventions Project (CIP) alongside the creation of the Congressional Inventions Caucus (CIC). The full-day event brought inventors from across the country to Capitol Hill to engage directly with lawmakers and congressional staff, share their personal innovation Read more…
The U.S. ban on flavored e-cigarettes was meant to curb youth vaping, but instead, it gave China control of the market. While American companies followed the rules, Chinese manufacturers flooded the U.S. with illegal flavored disposables—products they can’t even sell in their own country. Now, these unregulated imports make up Read more…
The United States is at a critical juncture in its competition with global rivals, particularly China, for leadership in critical and emerging technologies. This week, a coalition of conservative leaders sent a powerful message to Congress, urging action to safeguard America’s position as a global technology leader. The key to Read more…
The U.S. International Trade Commission recently released a 500-page report exploring the complex nexus of intellectual property, COVID-19, and access to essential drugs and tests. Despite the extensive analysis, the report notably refrains from drawing a definitive conclusion, leaving policymakers to navigate the nuanced terrain of innovation and public health. Read more…
In a letter addressed to Congress, and organized by Competitive Enterprise Institute, the undersigned organizations express their strong concerns regarding the Inflation Reduction Act (IRA), particularly its provisions related to prescription drug price controls. The coalition argues that the IRA’s prescription drug price control regime is unnecessary, as it focuses Read more…
President Biden’s populist approach to healthcare reform, focusing on price controls, has stirred controversy in the pharmaceutical industry. A new article by Market Institute President Charles Sauer in The Hill highlights the potential consequences of this strategy, including drug shortages and stifled innovation. By exploring the lessons learned from Japan’s Read more…
Just over a year ago, President Biden aimed to lead the nation towards innovation and collaboration, promoting research and unity to solve one of modern life’s biggest challenges—cancer. The United States has a long history of innovation, driven by a patent system that protects inventors and encourages investment in research Read more…
The Market Institute President Charles Sauer has a new article in Real Clear Markets on a bill recently introduced in Congress called the PREVAIL Act. If passed, it will help level the playing field for inventors, most notably by attempting to fix the Patent Trial and Appeals Board. He writes: Read more…
The Market Institute President Charles Sauer has a new article in The Washington Examiner’s Restoring America series on whether Congress is ready to finally pull the plug on the patent killing Patent Trial and Appeal Board. He writes: “We all know the basic plot of gladiator-style movies : The underdog battles in Read more…